chr10-68885620-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152709.5(STOX1):​c.1824A>C​(p.Glu608Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.21 in 1,614,008 control chromosomes in the GnomAD database, including 37,455 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2875 hom., cov: 32)
Exomes 𝑓: 0.21 ( 34580 hom. )

Consequence

STOX1
NM_152709.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:3

Conservation

PhyloP100: -1.56

Publications

39 publications found
Variant links:
Genes affected
STOX1 (HGNC:23508): (storkhead box 1) Enables RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in several processes, including positive regulation of G2/M transition of mitotic cell cycle; positive regulation of protein phosphorylation; and regulation of gene expression. Located in centrosome; cytosol; and nuclear lumen. Implicated in pre-eclampsia. Biomarker of Alzheimer's disease. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005174637).
BP6
Variant 10-68885620-A-C is Benign according to our data. Variant chr10-68885620-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1720.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.225 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STOX1NM_152709.5 linkc.1824A>C p.Glu608Asp missense_variant Exon 3 of 4 ENST00000298596.11 NP_689922.3 Q6ZVD7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STOX1ENST00000298596.11 linkc.1824A>C p.Glu608Asp missense_variant Exon 3 of 4 1 NM_152709.5 ENSP00000298596.6 Q6ZVD7-1

Frequencies

GnomAD3 genomes
AF:
0.176
AC:
26816
AN:
152074
Hom.:
2866
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0592
Gnomad AMI
AF:
0.326
Gnomad AMR
AF:
0.231
Gnomad ASJ
AF:
0.237
Gnomad EAS
AF:
0.0991
Gnomad SAS
AF:
0.233
Gnomad FIN
AF:
0.266
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.218
Gnomad OTH
AF:
0.178
GnomAD2 exomes
AF:
0.219
AC:
54508
AN:
249390
AF XY:
0.220
show subpopulations
Gnomad AFR exome
AF:
0.0595
Gnomad AMR exome
AF:
0.307
Gnomad ASJ exome
AF:
0.242
Gnomad EAS exome
AF:
0.0816
Gnomad FIN exome
AF:
0.261
Gnomad NFE exome
AF:
0.220
Gnomad OTH exome
AF:
0.215
GnomAD4 exome
AF:
0.213
AC:
312084
AN:
1461816
Hom.:
34580
Cov.:
36
AF XY:
0.215
AC XY:
156424
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.0535
AC:
1790
AN:
33480
American (AMR)
AF:
0.300
AC:
13407
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.243
AC:
6341
AN:
26136
East Asian (EAS)
AF:
0.153
AC:
6064
AN:
39700
South Asian (SAS)
AF:
0.230
AC:
19878
AN:
86258
European-Finnish (FIN)
AF:
0.258
AC:
13750
AN:
53398
Middle Eastern (MID)
AF:
0.195
AC:
1122
AN:
5768
European-Non Finnish (NFE)
AF:
0.214
AC:
237701
AN:
1111956
Other (OTH)
AF:
0.199
AC:
12031
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
15498
30995
46493
61990
77488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8120
16240
24360
32480
40600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.176
AC:
26835
AN:
152192
Hom.:
2875
Cov.:
32
AF XY:
0.180
AC XY:
13393
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0591
AC:
2455
AN:
41556
American (AMR)
AF:
0.232
AC:
3540
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.237
AC:
823
AN:
3470
East Asian (EAS)
AF:
0.0993
AC:
514
AN:
5176
South Asian (SAS)
AF:
0.233
AC:
1126
AN:
4824
European-Finnish (FIN)
AF:
0.266
AC:
2813
AN:
10580
Middle Eastern (MID)
AF:
0.177
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
0.218
AC:
14842
AN:
67990
Other (OTH)
AF:
0.177
AC:
373
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1110
2221
3331
4442
5552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.203
Hom.:
11361
Bravo
AF:
0.169
TwinsUK
AF:
0.208
AC:
772
ALSPAC
AF:
0.211
AC:
812
ESP6500AA
AF:
0.0583
AC:
225
ESP6500EA
AF:
0.215
AC:
1779
ExAC
AF:
0.212
AC:
25628
Asia WGS
AF:
0.202
AC:
700
AN:
3478
EpiCase
AF:
0.214
EpiControl
AF:
0.218

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Preeclampsia/eclampsia 4 Pathogenic:1Benign:1
May 01, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jan 06, 2020
Reproductive Health Research and Development, BGI Genomics
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

NM_152709.4:c.1824A>C in the STOX1 gene has an allele frequency of 0.307 in European (Finnish) subpopulation in gnomAD dacabase. 7171 homozygous occurrences are observed in the gnomAD database. This evidence suggests the variant to be classified as benign. ACMG/AMP criteria applied: BA1, BS2. -

not specified Benign:1
Oct 28, 2020
H3Africa Consortium
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.06, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.0070
DANN
Benign
0.090
DEOGEN2
Benign
0.0072
T;T;.
Eigen
Benign
-2.0
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.051
N
LIST_S2
Benign
0.34
.;T;T
MetaRNN
Benign
0.0052
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.6
N;N;.
PhyloP100
-1.6
PrimateAI
Benign
0.23
T
PROVEAN
Benign
0.96
N;N;.
REVEL
Benign
0.16
Sift
Benign
0.98
T;T;.
Sift4G
Benign
0.68
T;T;.
Polyphen
0.0
B;B;.
Vest4
0.016
MutPred
0.35
Loss of sheet (P = 0.0817);Loss of sheet (P = 0.0817);.;
MPC
0.064
ClinPred
0.0042
T
GERP RS
1.1
Varity_R
0.041
gMVP
0.024
Mutation Taster
=99/1
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10509305; hg19: chr10-70645376; COSMIC: COSV53813997; API